M Ventures — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Altoida builds a multi-modal Digital NeuroMarker Platform that combines augmented reality, sensor fusion, and explainable AI in a 10-minute self-administered assessment to detect early signs of Mild Cognitive Impairment and Alzheimer's disease.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsAlpana VenturesEisai Innovation, Inc.Hikma VenturesPolytech Ecosystem VenturesVI PartnersWhitecap Venture Partners+2 more
Metalenz develops metasurface optics technology for optical sensing in consumer and industrial devices.
Deep TechHardwareSemiconductorsStoneham, US
Federico Capasso(Director)Rob Devlin(Founder)in
BoardXuhui Shao(Director)in
Co-investorsBantam GroupBraemar Energy VenturesFoothill VenturesGlobal BrainIntel CapitalNeotribe Ventures+7 more
Nucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets.
AI & Machine LearningBiotechDeep Tech
Co-investorsOxford Science EnterprisesPfizer Venture InvestmentsBritish Patient CapitalJJDCPfizer Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.